Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Hearne Michael S Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 185 shares @ $3.468, valued at $641.6
Granted 185 options to buy @ $4.08, valued at $754.8
04/18/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 173 shares @ $3.7145, valued at $642.6
Granted 173 options to buy @ $4.37, valued at $756
04/04/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 177 shares @ $3.6295, valued at $642.4
Granted 177 options to buy @ $4.27, valued at $755.8
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 169 shares @ $3.791, valued at $640.7
Granted 169 options to buy @ $4.46, valued at $753.7
02/02/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 1,675 shares @ $3.9355, valued at $6.6k
Granted 1,675 options to buy @ $4.63, valued at $7.8k
01/19/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 148 shares @ $4.182, valued at $618.9
Granted 148 options to buy @ $4.92, valued at $728.2
01/14/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 78,552 options to buy @ $4.81, valued at $377.8k
01/04/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 157 shares @ $3.9185, valued at $615.2
Granted 157 options to buy @ $4.61, valued at $723.8
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2021 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Sold 193,403 shares @ $4.1008, valued at $793.1k
Sold 6,597 shares @ $3.9514, valued at $26.1k
Sold 63,745 shares @ $3.9461, valued at $251.5k
Sold 136,255 shares @ $3.7586, valued at $512.1k
Sold 41,290 shares @ $3.6644, valued at $151.3k
11/19/2021 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 468,849 shares @ $2.6583, valued at $1.2M
Sold 31,151 shares @ $1.9941, valued at $62.1k
Sold 500,000 shares @ $2.0161, valued at $1M
Sold 287,577 shares @ $2.1985, valued at $632.2k
Sold 212,423 shares @ $1.9708, valued at $418.6k
Sold 500,000 shares @ $1.8812, valued at $940.6k
Sold 381,842 shares @ $1.8925, valued at $722.6k
Sold 365,289 shares @ $1.9161, valued at $699.9k
11/17/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 181 shares @ $3.4085, valued at $616.9
Granted 181 options to buy @ $4.01, valued at $725.8
11/02/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 181 shares @ $3.417, valued at $618.5
Granted 181 options to buy @ $4.02, valued at $727.6
10/19/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 183 shares @ $3.366, valued at $616
Granted 183 options to buy @ $3.96, valued at $724.7
10/04/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 182 shares @ $3.3915, valued at $617.3
Granted 182 options to buy @ $3.99, valued at $726.2
09/17/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 546 shares @ $3.3915, valued at $1.9k
Granted 546 options to buy @ $3.99, valued at $2.2k
08/03/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 201 shares @ $3.0685, valued at $616.8
Granted 201 options to buy @ $3.61, valued at $725.6
07/19/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 193 shares @ $3.196, valued at $616.8
Granted 193 options to buy @ $3.76, valued at $725.7
07/02/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 170 shares @ $3.638, valued at $618.5
Granted 170 options to buy @ $4.28, valued at $727.6
06/17/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 148 shares @ $4.165, valued at $616.4
Granted 148 options to buy @ $4.9, valued at $725.2
06/02/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 169 shares @ $3.655, valued at $617.7
Granted 169 options to buy @ $4.3, valued at $726.7
06/01/2021 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Bought 1,286 shares @ $4.4984, valued at $5.8k
Bought 184,642 shares @ $4.4734, valued at $826k
Bought 15,358 shares @ $4.292, valued at $65.9k
Bought 43,734 shares @ $4.5277, valued at $198k
05/26/2021 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Bought 104,403 shares @ $3.6803, valued at $384.2k
Bought 95,597 shares @ $3.7748, valued at $360.9k
Bought 31,782 shares @ $3.8347, valued at $121.9k
Bought 166,932 shares @ $4.2578, valued at $710.8k
05/18/2021 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 193 shares @ $3.196, valued at $616.8
Granted 193 options to buy @ $3.76, valued at $725.7
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy